PI3K/AKT inhibitors in patients with refractory renal cell carcinoma: what have we learnt so far?

Ann Oncol. 2017 May 1;28(5):914-916. doi: 10.1093/annonc/mdx104.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Renal Cell*
  • Cell Line, Tumor
  • Humans
  • Kidney Neoplasms
  • Phosphatidylinositol 3-Kinases*
  • Proto-Oncogene Proteins c-akt

Substances

  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt